Octreotide treatment of cancer chemoradiotherapy-induced diarrhoea: a meta-analysis of randomized controlled trials

BACKGROUND: Patients receiving radiotherapy and chemotherapy have a high risk developing to an acute chemoradiotherapy-induced diarrhea (RID). The clinical efficacy of octreotide in controlling chemoradiotherapy-induced diarrhea remains controversial. We performed a meta-analysis of randomized contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, De-Jian, Li, Zeng-Jun, Wang, Xi-Yan, Zhu, Xian-Jun, Sun, Yan-Lai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797939/
https://www.ncbi.nlm.nih.gov/pubmed/35116981
http://dx.doi.org/10.21037/tcr.2019.09.49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797939/
https://www.ncbi.nlm.nih.gov/pubmed/35116981
http://dx.doi.org/10.21037/tcr.2019.09.49

Ejemplares similares